NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,000 | – | 8,605 | +2531.5% | 0.00% | – |
| Q3 2020 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 327 | -92.7% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 4,500 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | +133.3% | 4,500 | +125.0% | 0.00% | – |
| Q2 2019 | $3,000 | -92.7% | 2,000 | -87.3% | 0.00% | – |
| Q1 2019 | $41,000 | -62.7% | 15,795 | -76.3% | 0.00% | -100.0% |
| Q4 2018 | $110,000 | -36.4% | 66,724 | +86.7% | 0.00% | 0.0% |
| Q3 2018 | $173,000 | +367.6% | 35,734 | +500.3% | 0.00% | – |
| Q2 2018 | $37,000 | -88.3% | 5,953 | -84.4% | 0.00% | -100.0% |
| Q1 2018 | $316,000 | -53.7% | 38,121 | -43.1% | 0.00% | -40.0% |
| Q4 2017 | $683,000 | +121.8% | 66,980 | +99.2% | 0.01% | +66.7% |
| Q3 2017 | $308,000 | +211.1% | 33,620 | +147.1% | 0.00% | +200.0% |
| Q2 2017 | $99,000 | – | 13,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,971,014 | $6,413,000 | 4.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,711,454 | $4,788,000 | 0.66% |
| Proxima Capital Management, LLC | 206,000 | $266,000 | 0.36% |
| Nantahala Capital Management | 4,610,000 | $5,947,000 | 0.18% |
| Alambic Investment Management, L.P. | 219,090 | $283,000 | 0.18% |
| Wealthstar Advisors, LLC | 73,295 | $95,000 | 0.06% |
| ALGERT GLOBAL LLC | 77,845 | $100,000 | 0.04% |
| Western Standard LLC | 25,935 | $33,000 | 0.02% |
| Allred Capital Management, LLC | 24,995 | $33,000 | 0.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $414,000 | 0.02% |